Dexamethasone
Dexamethasone is a corticosteroid used across multiple forms and routes to treat inflammation, allergic conditions, endocrine disorders, certain blood and autoimmune diseases, eye conditions, and multiple myeloma.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 96 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Dexamethasone: Patient Information Guide
A plain-language walkthrough of Dexamethasone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Dexamethasone is a corticosteroid available in multiple products and formulations, each approved for specific uses:
- Oral tablets and solutions (including Dexamethasone Intensol and TaperDex): severe allergic conditions (asthma, atopic dermatitis, contact dermatitis, drug reactions, allergic rhinitis, serum sickness); inflammatory skin diseases (Stevens-Johnson syndrome, pemphigus, mycosis fungoides); endocrine disorders (adrenal insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, cancer-related high calcium); gastrointestinal diseases (ulcerative colitis, regional enteritis); blood disorders; rheumatic conditions; kidney disease with heavy protein loss; nervous system conditions; and respiratory diseases including tuberculosis complications
- Hemady (oral tablet): used in combination with other anti-myeloma medicines specifically for multiple myeloma in adults
- Injectable forms (IV/IM — dexamethasone sodium phosphate): used when oral therapy is not possible for the same broad range of endocrine, rheumatic, inflammatory, and other conditions; also used in shock unresponsive to conventional therapy when adrenal insufficiency is present or suspected
- Intra-articular/intralesional/soft tissue injection: local inflammation in joints and soft tissues
- Dextenza (intracanalicular insert): eye inflammation and pain after eye surgery; eye itching from allergic conjunctivitis (adults and children 2 years and older)
- Ozurdex (intravitreal implant): macular edema after branch or central retinal vein occlusion; non-infectious uveitis in the posterior eye; diabetic macular edema
- Dexycu (intraocular injection): inflammation after eye surgery
- Maxidex (ophthalmic suspension) and dexamethasone sodium phosphate eye drops: steroid-responsive inflammatory conditions of the eye (conjunctiva, cornea, anterior segment)
- Dexamethasone sodium phosphate ophthalmic/otic solution: steroid-responsive eye inflammation and outer ear canal inflammation
- Seacall topical ointment: skin conditions including contact dermatitis, neurodermatitis, seborrheic dermatitis, and chronic eczema
⚙️How it works▾
Dexamethasone is a synthetic corticosteroid — it mimics and amplifies the action of cortisol, a natural hormone made by the adrenal glands. It works mainly by dampening inflammation and dialing down overactive immune responses throughout the body. In multiple myeloma, it also directly triggers the death of cancer cells (a process called apoptosis), though the exact mechanism is not fully understood. Because it has very low mineralocorticoid activity — meaning it has minimal effect on sodium and water balance compared to some other steroids — it is often preferred when fluid retention is a concern.
💊How it's taken▾
How dexamethasone is taken depends entirely on the product and condition being treated. Oral tablets and liquid solutions are taken by mouth; a high-fat meal does not meaningfully affect overall drug absorption, though taking it with food may ease stomach upset. Injectable forms are given by a healthcare provider — by vein (IV), into muscle (IM), into a joint, or into soft tissue. Eye-specific products are placed in or around the eye by a trained provider: Dextenza is a small dissolvable insert placed in the tear duct, Ozurdex is a tiny implant injected into the back of the eye, and Dexycu is a single injection given at the end of eye surgery.
- Dosage and frequency vary widely — always follow your prescriber's exact instructions
- Never stop oral or injectable dexamethasone abruptly after extended use — doses must be tapered gradually
- If you miss a dose, follow the guidance on your prescription label or call your pharmacist
🤒Side effects — in detail▾
Dexamethasone can cause a range of side effects depending on the form, dose, and length of use:
- Elevated blood sugar (glucose), which can worsen or unmask diabetes
- High blood pressure and fluid retention
- Mood changes, insomnia, irritability, euphoria, or depression
- Increased appetite and weight gain
- Increased susceptibility to infections
- With eye products: increased eye pressure, cataracts, conjunctival hemorrhage (bloodshot appearance), and eye pain
- Bone thinning (osteoporosis) with long-term use
- Muscle weakness at high doses
Seek medical attention right away if you notice signs of serious infection, sudden severe stomach pain, major mood or behavior changes, vision changes, or symptoms of a blood clot (leg swelling, chest pain, or shortness of breath).
⚠️Warnings & precautions▾
- Immune suppression and infection risk: Dexamethasone suppresses the immune system. It can make you more vulnerable to bacterial, viral, fungal, and parasitic infections — and can mask symptoms so infections seem milder than they are. Tuberculosis, hepatitis B, chickenpox, measles, and fungal infections all carry special risks.
- Do not stop abruptly: Stopping suddenly after extended use can trigger adrenal crisis — a life-threatening drop in the body's stress hormones. Doses must be reduced gradually.
- Blood sugar: Dexamethasone raises blood glucose and can worsen or cause diabetes. Regular monitoring is essential.
- Bone loss: Long-term use increases the risk of osteoporosis and fractures, especially in older adults and postmenopausal women.
- Blood clots: Risk of dangerous blood clots (venous and arterial thromboembolism) is elevated, particularly in combination with certain multiple myeloma medications.
- Mood and psychiatric effects: Serious mood disturbances — including euphoria, depression, insomnia, psychosis, and suicidal thoughts — can occur, sometimes within days of starting treatment.
- Pregnancy: Dexamethasone can cause birth defects (including cleft palate) and low birth weight. Women who are pregnant or could become pregnant should discuss risks with their doctor.
- Kaposi's sarcoma: A rare skin cancer has been reported in patients on long-term corticosteroid therapy.
🔀What it interacts with▾
Dexamethasone interacts with several medications and should be used carefully alongside:
- Strong CYP3A4 inhibitors (e.g., itraconazole): Dramatically increase dexamethasone blood levels, raising the risk of side effects — avoid if possible
- Strong CYP3A4 inducers: Lower dexamethasone levels and may reduce its effectiveness — avoid if possible
- NSAIDs and aspirin: Combined use increases the risk of stomach ulcers and bleeding
- Blood thinners (anticoagulants): Dexamethasone may blunt their effect; close monitoring of clotting is needed
- Antidiabetic drugs: Dexamethasone raises blood sugar, potentially requiring higher doses of diabetes medication
- Digitalis glycosides (heart medicines): Low potassium caused by dexamethasone can trigger dangerous heart rhythms
- Cyclosporine: Both drugs become more active together; seizures have been reported
- Estrogen-containing medicines (including birth control pills): May increase dexamethasone exposure and side effects
- Live vaccines: Must not be given to patients on immunosuppressive doses of dexamethasone
- Cholestyramine and ephedrine: Can reduce dexamethasone levels and efficacy
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your prescriber if you have or have had diabetes — dexamethasone raises blood sugar
- Tell your prescriber about any active or recent infections, including tuberculosis, hepatitis B, chickenpox, measles, or fungal infections
- Tell your prescriber if you are pregnant, planning to become pregnant, or breastfeeding — dexamethasone can harm an unborn baby and passes into breast milk
- Females of reproductive potential should use effective contraception during treatment and for at least one month after the final dose
- Tell your prescriber if you have heart failure, high blood pressure, or recently had a heart attack
- Tell your prescriber if you have osteoporosis or risk factors for it — especially if you are an older adult or postmenopausal woman
- Tell your prescriber if you have glaucoma or elevated eye pressure (particularly relevant for Ozurdex, which is contraindicated in certain glaucoma patients)
- Tell your prescriber if you have a torn or ruptured posterior lens capsule in your eye (Ozurdex is contraindicated)
- Safety and effectiveness of Hemady have not been established in children
- Older adults are at higher risk for bone loss, fractures, and other corticosteroid-related side effects; bone density should be monitored regularly
- Tell your prescriber if you have thyroid disease — thyroid status affects how quickly the body clears dexamethasone
- Tell your prescriber if you have a suspected pheochromocytoma (a rare adrenal tumor) — corticosteroids can trigger a dangerous crisis
🚑If you take too much▾
There is no specific antidote for a dexamethasone overdose. Treatment focuses on supportive and symptomatic care. In the case of an acute oral overdose, a healthcare provider may consider measures such as gastric lavage (stomach pumping) or induced vomiting depending on the patient's condition. If you suspect an overdose, seek emergency medical care immediately.
📡Pharmacodynamics — effects in the body▾
After a single oral dose of dexamethasone, the drug begins suppressing the body's own cortisol production. Cortisol suppression peaks at around 12 hours after the dose. The body's cortisol levels then gradually recover, returning to near normal within about 3 days after a single dose. This means even a single dose can meaningfully affect the body's stress hormone system for several days.
🔬Pharmacokinetics — how your body processes it▾
When taken orally, dexamethasone is absorbed relatively quickly — peak blood levels are typically reached within about 1 hour, though this can range from 30 minutes to 4 hours. A high-fat meal does not significantly affect overall absorption but may slightly reduce the peak concentration. Dexamethasone is about 77% bound to proteins in the blood. It is broken down (metabolized) mainly by the liver enzyme CYP3A4, with less than 10% leaving the body unchanged in the urine. The half-life — the time for blood levels to drop by half — is approximately 4 hours, though its effects on the body last much longer than this figure suggests.
📦How to store it▾
Store and Dispense Store at 20° to 25°C (68° to 77°F). Dispense in a tight light-resistant, child-resistant container as defined in the USP/NF. Do not freeze.
📄 Written from Dexamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Dexamethasone
221 supplements and herbal products have documented interactions with Dexamethasone in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 4
- Moderate · 182
- Minor · 35
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Dexamethasone has been associated with lower levels of 8 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 1
- Moderate · 5
- Unrated · 2
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Dexamethasone — the kind of thing our pharmacy team would talk through with you at the counter.
Why has my doctor prescribed dexamethasone — it seems to be used for so many different things? ▾
Can I just stop taking dexamethasone if I feel better or if I'm worried about side effects? ▾
I have diabetes. Is dexamethasone safe for me to take? ▾
Are there medicines I need to avoid while taking dexamethasone? ▾
I'm pregnant. Is it safe to take dexamethasone? ▾
What side effects should I just watch for versus which ones mean I need to call my doctor right away? ▾
Is Dexamethasone available over the counter? ▾
When was Dexamethasone first available? ▾
Who makes Dexamethasone? ▾
💬 Answers drafted from Dexamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Dexamethasone comes
Dexamethasone is available in 6 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
Injection
Oral solution
Eye drops
Insert or device
Topical cream, ointment or gel
📊 Dexamethasone across the U.S. market
How Dexamethasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (42) · Kit (2) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Dexamethasone is used
A general measure of how commonly Dexamethasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Dexamethasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Dexamethasone prescribed? Of the 1,596 medications we measure, Dexamethasone ranks #110 by Medicaid prescriptions — more than 93% of them.
Utilization by Dexamethasone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
dexamethasone 4 MG Oral Tablet Most dispensed
Summed across the 13 of 166 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197582
dexamethasone phosphate 10 MG/ML Injectable Solution
Summed across the 7 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309696
1 ML dexamethasone phosphate 4 MG/ML Injection
Summed across the 8 of 35 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812194
dexamethasone phosphate 4 MG/ML Injectable Solution
Summed across the 13 of 66 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1116927
1 ML dexamethasone phosphate 10 MG/ML Injection
Summed across the 7 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812079
dexamethasone 0.1 MG/ML Oral Solution
Summed across the 4 of 13 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309686
dexamethasone 6 MG Oral Tablet
Summed across the 11 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197583
dexamethasone 2 MG Oral Tablet
Summed across the 10 of 31 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197581
dexamethasone 1 MG Oral Tablet
Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197579
dexamethasone phosphate 1 MG/ML Ophthalmic Solution
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 226343
dexamethasone 1 MG/ML Oral Solution
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309684
dexamethasone 0.75 MG Oral Tablet
Summed across the 6 of 40 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 343033
dexamethasone 0.5 MG Oral Tablet
Summed across the 6 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197577
dexamethasone 0.7 MG Drug Implant
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854177
dexamethasone 0.4 MG Drug Implant
Summed across the 2 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2108015
1 ML dexamethasone phosphate 4 MG/ML Prefilled Syringe
Summed across the 2 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812095
dexamethasone 1 MG/ML Ophthalmic Suspension
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309692
dexamethasone 1.5 MG Oral Tablet
Summed across the 5 of 38 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197580
1 ML dexamethasone phosphate 10 MG/ML Prefilled Syringe
Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2099700
dexamethasone 20 MG Oral Tablet
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2261802
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Dexamethasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 106 of 529 listed Dexamethasone NDCs with Medicaid activity.
🔍 Compare Dexamethasone products
A representative set of FDA-listed product records for Dexamethasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 0.7 mg | Intravitreal | Allergan, Inc. × 3 listings | NDA | View NDC → |
| 1 mg/mL | Ophthalmic | Harrow Eye, LLC | NDA | View NDC → |
| 💊Injection | ||||
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intramuscular, Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| 4 mg/mL | Intramuscular; Intravenous | A-S Medication Solutions | ANDA | Find on DailyMed ↗ |
| 10 mg/mL | Intramuscular, Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Advanced Rx of Tennessee, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Amneal Pharmaceuticals LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Amneal Pharmaceuticals LLC × 6 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Armas Pharmaceuticals | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Asclemed USA, Inc. × 6 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Asclemed USA, Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Asclemed USA, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Asclemed Usa Inc. × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | AuroMedics Pharma LLC × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular; Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 4 mg/mL | Intramuscular, Intravenous | Cardinal Health 107, LLC | ANDA | View NDC → |
| 4 mg/mL | Intramuscular; Intravenous | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Cardinal Health 107, LLC | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Cardinal Health 107, LLC | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Civica, Inc. | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Civica, Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Civica, Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Civica, Inc. | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Eugia US LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Eugia US LLC × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Eugia US LLC | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Eugia US LLC | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular, Intravenous | Eugia US LLC | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular; Intravenous | Eugia US LLC | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intramuscular; Intravenous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC × 8 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Fresenius Kabi USA, LLC × 4 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | General Injectables & Vaccines, Inc. | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | General Injectables and Vaccines, Inc | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | General Injectables and Vaccines, Inc. × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Gland Pharma Limited × 4 listings | ANDA | View NDC → |
| 10 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Gland Pharma Limited | ANDA | View NDC → |
| 10 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Gland Pharma Limited | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Henry Schein, Inc. × 4 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Henry Schein, Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | HF Acquisition Co LLC, DBA HealthFirst × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| 4 mg/mL | Intramuscular; Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular; Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Hikma Pharmaceuticals USA Inc. × 4 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | IT3 Medical LLC | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Medical Purchasing Solutions, LLC × 8 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Medical Purchasing Solutions, LLC × 8 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Medical Purchasing Solutions, LLC × 2 listings | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 100 mg/10 mL | Intramuscular; Intravenous | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Medical Purchasing Solutions, LLC. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Micro Labs Limited × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Mylan Institutional LLC × 6 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Mylan Institutional LLC × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Mylan Institutional LLC × 2 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Remedyrepack Inc. | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Remedyrepack Inc. | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Remedyrepack Inc. | ANDA | View NDC → |
| 4 mg/mL | Intra-articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Somerset Therapeutics, LLC × 3 listings | ANDA | View NDC → |
| 4 mg/mL | Intra-articular; Intralesional; Intramuscular; Intravenous; Soft Tissue | Somerset Therapeutics, LLC × 3 listings | ANDA | View NDC → |
| 10 mg/mL | Intramuscular, Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 10 mg/mL | Intramuscular; Intravenous | Somerset Therapeutics, LLC × 2 listings | ANDA | View NDC → |
| 💊Insert or device | ||||
| 0.7 mg | — | Synergy Health AST, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Oral solution | ||||
| 0.5 mg/5 mL | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Kanchan Healthcare Inc | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Kesin Pharma Corporation | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Marlex Pharmaceuticals, Inc | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Morton Grove Pharmaceuticals, Inc. | ANDA | Find on DailyMed ↗ |
| 0.5 mg/5 mL | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/5 mL | Oral | STI Pharma LLC | ANDA | View NDC → |
Showing 200 of 567 products — FDA National Drug Code Directory. See every product, package size and price: browse all 567 Dexamethasone NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dexamethasone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dexamethasone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Dexamethasone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3264 11 dose forms · 29 strengths
-
Dose form (SCDF) Drug Implant RxCUI 854176In current FDA listings -
Dose form (SCDF) Injectable Solution RxCUI 371725In current FDA listingsClinical drug / strength (SCD) phosphate 10 MG/MLRxCUI 309696phosphate 4 MG/MLRxCUI 1116927sodium phosphate 0.4 MG/MLRxCUI 1249712sodium phosphate 4 MG/MLRxCUI 10494002 MG/MLRxCUI 4356813 MG/MLRxCUI 880649 -
Dose form (SCDF) Injectable Suspension RxCUI 371721In current FDA listingsClinical drug / strength (SCD) acetate 8 MG/MLRxCUI 1374372 -
Dose form (SCDF) Injection RxCUI 1812073In current FDA listingsClinical drug / strength (SCD) 0.005 ML dexamethasone 103.4 MG/MLRxCUI 20454041 ML dexamethasone phosphate 10 MG/MLRxCUI 18120791 ML dexamethasone phosphate 4 MG/MLRxCUI 1812194 -
Dose form (SCDF) Ophthalmic Solution RxCUI 377418In current FDA listingsClinical drug / strength (SCD) phosphate 1 MG/MLRxCUI 226343 -
Dose form (SCDF) Ophthalmic Suspension RxCUI 371723In current FDA listingsClinical drug / strength (SCD) 1 MG/MLRxCUI 309692 -
Dose form (SCDF) Oral Solution RxCUI 371728In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 371729In current FDA listings -
Dose form (SCDF) Prefilled Syringe RxCUI 1812094In current FDA listingsClinical drug / strength (SCD) 1 ML dexamethasone phosphate 10 MG/MLRxCUI 20997001 ML dexamethasone phosphate 4 MG/MLRxCUI 1812095 -
Dose form (SCDF) Topical Ointment RxCUI 2691148In current FDA listingsClinical drug / strength (SCD) 0.00075 MG/MGRxCUI 2691149 -
Dose form (SCDF) Topical Solution RxCUI 393151No current FDA listingClinical drug / strength (SCD) 1 MG/MLRxCUI 388755
Look up RxCUI 3264 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Dexamethasone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Dexamethasone belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 96 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Edenbridge Pharmaceuticals LLC. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.